Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Valuation
Growth
Negative earnings, no valuation support
Negative FCF, no valuation support
FCF negative, burning cash after capex
Business Quality & Capital Allocation
Heavy dilution above 5%
Net cash position, no leverage concern
Below 8%, may not cover cost of capital
GH Research (GHRS) quality: score, margins and returns
GH Research (GHRS) scores 10/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 4 metrics each scored 0 to 100 and -20.9% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.
Frequently asked
Is GH Research (GHRS) a high-quality business?+
GH Research scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -20.9% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does GH Research's quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from GHRS's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where GH Research scores well and where it falls behind.
What is GH Research's return on invested capital (ROIC)?+
GH Research earns about -20.9% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to GHRS's margins and growth on this scorecard to judge durability.
Peers
Biotechnology · Pick stocks to compare with GHRS
Held by ETFs
GHRS is in 7 US ETFs. The largest of them, with GHRS's weight in each:
iShares Biotechnology ETFIBB0.07%of the fund
ProShares Ultra Nasdaq BiotechnologyBIB0.07%of the fund
iShares MSCI Ireland ETFEIRL1.42%of the fund
Invesco Nasdaq Biotechnology ETFIBBQ0.12%of the fund
- BBVirtus Biotech Clinical Trials ETFBBC0.89%of the fund
- PSAdvisorShares Psychedelics ETFPSIL4.31%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GHRS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.